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ABSTRACT
Purpose: Recruitment to trials is often difficult. Many
trials fail to meet recruitment targets resulting in
underpowered studies which waste resources and the
time of those who participated. While there is evidence
that many people are willing to take part in research,
particularly if it involves a condition from which they
suffer, researchers are unable to easily contact such
people often relying on busy clinicians to identify them.
Many clinicians perceive themselves as too busy to
take part in research activities. The Scottish Health
Research Register SHARE adopts an approach which
asks the public to consent to their data held in National
Health Service databases to be used to determine their
suitability for research projects. Additionally,
participants can consent for spare blood, left after
routine venepuncture to be automatically identified in
the laboratory and stored for future research studies.
Participants: Anyone over the age of 16 years in
Scotland can participate. Participants are approached
through a range of methods including directly at
outpatient clinics and general practitioners practices,
leaflets with hospital letters and personal email from
employers.
Findings to date: SHARE has recruited around
130 000 people. SHARE has demonstrated that it can
quickly and efficiently recruit to studies, over 20 until
now. In addition, it can be used to administer
questionnaire studies by email and recruit to patient
and public involvement groups.
Future plans: SHARE continues to steadily recruit
with the ambition of eventually achieving 1 000 000
people in Scotland. We are steadily increasing the
number of data sets we use for identifying participants.
We are adding a mobile app which will facilitate
dissemination about research and allow the collection
of physiological and activity data if desired. We
anticipate that SHARE will soon become the main
source of health research recruitment in Scotland.
BACKGROUND
Although randomised controlled trials
remain the gold standard for interventional
medical research, recruiting participants is
difﬁcult.1 In a study by Sully et al,2 only 55%
of trials recruited their originally speciﬁed
target sample size, with 78% recruiting 80%
of their target. There is no evidence that this
has improved in recent years. Such trials are
likely to be underpowered and therefore
waste scarce research funding and the time
of their participants.3 Although in some spe-
cialties, such as oncology, clinical trials are
well integrated into day-to-day care, most
people have never taken part in clinical
research with few being approached and
<1% of people in the UK taking part.4
However, a census-wide poll by the National
Institute for Health Research in the UK in
2014 revealed that almost 90% of people
would be willing to take part in research if
it was into a condition which they had
Strengths and limitations of this study
▪ SHARE has demonstrated that it can recruit large
numbers of volunteers who have intimated their
interest in taking part in research, and the ability
to use National Health Service linked data to
identify those potentially suitable for research
projects.
▪ SHARE has successfully recruited to projects
including some ‘hard to reach’ participants.
▪ SHARE has obtained wide support from health
boards, professional bodies, patient advocacy
groups and the research community.
▪ While potentially able to exploit one of the most
wide-ranging sets of data in the world, SHARE,
like all similar data sets, is limited by the accur-
acy and completeness of clinical coding.
▪ Recruitment to SHARE is labour intensive and
currently supported by external grant funding.
Sustainability may become an issue in future if
the process cannot be supported by usage
payments.
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experienced.5 Potential participants face difﬁculties,
though, in ﬁnding relevant information on research
studies in which they may be interested.
For most clinical studies, identiﬁcation of potential
participants relies on clinicians either opportunistically
identifying potential study participants during encoun-
ters with patients or searching health records and subse-
quently contacting the patients on behalf of researchers
to ask if they are interested in taking part. Clinicians per-
ceive themselves as busier than ever before and many
declare themselves too busy to take part in research.6
Moreover, even when clinicians do agree to recruit to a
study, they often use their knowledge of the patient to
decide not to offer participation in a trial because they
perceive that the patient will either not respond or
decline.7 The next step in the standard process is that
participants then have to respond to their clinician or
directly to the researcher when often a baseline visit is
required to conﬁrm eligibility. Increasingly, a genetic
proﬁle may also be required. Each stage represents a
challenge to recruitment, reducing participation rates at
each point.
Attempts to make this process more efﬁcient include
the setting up of registers of patients who have declared
an interest in taking part in research. Academic health-
care providers have developed mechanisms to invite
patients but these are often disease-based registers set
up by institutions, with some linkage to the institution’s
data sets or by commercial organisations focused on
drug discovery, offering incentives such as medication
information in return, but who rely on self-declared
medical history.8 9 National programmes such as ‘Care.
Data’ attempted to make use of information held on
National Health Service (NHS) England linked data sets
to identify people who might be suitable for studies.
Care.Data assumed consent unless patients actively
opted out of sharing data. This led to protests from
some members of the public and the British Medical
Association10 which were escalated by some high proﬁle
errors in the early stages of the project.11 The project
was subsequently suspended.
SHARE
The Scottish Health Research register SHARE adopts an
approach which seeks individual consent to be
approached to participate in research from the outset.
Since inception in 2011, about 130 000 individuals have
registered either by paper form or online at http://www.
registerforshare.org.uk (ﬁgure 1).
SHARE asks potential participants to allow their infor-
mation currently held in NHS data sets to be used
securely to identify research studies for which they may
be suitable (see ﬁgure 2). This is facilitated through the
use of the Community Health Index (CHI) number
which is the unique patient identiﬁer used for interac-
tions in the Scottish health service.12 Participants’
contact details are regularly updated in SHARE through
regular downloads from their primary care practices and
removed if they die or leave Scotland. Participants can
choose how they wish to be told about studies for which
they may be suitable (telephone, email or letter) and
how many times they wish to be contacted each year (up
to a maximum of 4). Currently, SHARE is using mainly
hospital discharge data and prescribing data to identify
potential participants for studies as these are considered
most accurate, but we intend to make use of other data
sets including data from general practitioners (GPs) as
they become available.
SHARE- genomics
Following on the success of a Wellcome Trust funded
project Genetics of Share (goSHARE), which had suc-
cessfully been run as a pilot in NHS Tayside, SHARE par-
ticipants are now additionally given the option to give
consent for blood remaining after routine tests have
been performed, to be stored and subsequently used for
approved medical research. This makes use of an auto-
mated system, running within NHS laboratories, which
uses the CHI number to identify and automatically col-
lates and stores, at −80OC, participants’ residual routine
haematology samples, until 10 mL has been collected
(see ﬁgure 3). The collated samples can then be used
for research linked to the participant’s medical history.
Providing ethical approval has been granted, this also
allows for the use of novel biomarkers including genom-
ics to prescreen and enrich cohorts for stratiﬁed medical
studies. Currently, over 99% of registrants provide
consent for the use of these ‘spare bloods’ and over
40 000 blood samples have been intercepted so far.
Researchers’ access to SHARE
Researchers who wish to use SHARE for recruitment can
do so at two stages: ﬁrst, at the time of application for
research funding to see if SHARE is likely to be a suit-
able vehicle for recruitment; and second, following
funding for recruitment. Researchers are asked to com-
plete an online request which speciﬁcally asks about the
proposed recruitment inclusion and exclusion criteria,
and, if funded, conﬁrmation of ethical approval and
funding along with the proposed protocol. This request
is immediately emailed to the Studies Access Committee
which assesses the suitability of the research for SHARE.
Approval is based on the importance and quality of the
study, the likelihood that SHARE will be able to ﬁnd the
desired number of recruits and the capacity of the
organisation to undertake the research. Priority is given
to studies funded by ‘eligible funders’13 and commercial
studies.
To optimise successful recruitment, a plan of the most
appropriate data sets to search is drawn up by the
SHARE team in consultation with the safe haven staff.
Currently, this is often a combination of community pre-
scribing data, and inpatient and outpatient codes, but
we expect to be able to use the full range of available
data sets (ﬁgure 2) in the next year when primary care
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electronic medical record data may also be included.
Searches are currently carried out in local safe havens
depending on where in Scotland the researchers wish to
conduct their research. Once potential participants are
identiﬁed, depending on their contact preferences, they
are provided with details of the project by telephone,
email or letter explaining that the project is one in
which they may be interested. Those expressing an inter-
est and giving consent have their contact details passed
to the research team. The participant’s progress is then
Figure 1 SHARE reaches 100 000 registrants.
Figure 2 Scottish linked data sets. Currently, data from hospital discharges, hospital outpatient attendances and primary care
prescribing data sets are those most widely used by SHARE. NHS, National Health Service.
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tracked by SHARE noting if they are recruited and then
removing the ability to contact the participants tempor-
arily from the register until their participation in the
research project is scheduled to ﬁnish.
Use of SHARE for public and patient involvement
Researchers who would like to involve the general public
in designing, conducting and analysing their research
can do so through SHARE. The general public or
people either with or without a speciﬁc disease/condi-
tion can be approached and, if willing, are put in
contact with the research team.
Progress
SHARE started as a feasibility project supported by the
Scottish Government Chief Scientist Ofﬁce, NHS Lothian
and NHS Tayside in 2011. Early research14 showed that
the concept was popular with potential participants,
researchers and clinicians as long as it was strongly asso-
ciated with the NHS, that conﬁdentiality was assured and
that workload for frontline staff was not increased.
Altruism and the hope that research may beneﬁt either
them or family members were considered major drivers
to participation. Further funding from the Chief Scientist
Ofﬁce to build the register allowed experimentation with
a variety of different forms of recruitment.
Recruitment to SHARE
Those signing up electronically indicate their main
source of information about SHARE. Table 1 outlines
the recruitment methods we have employed, as well as
their strengths and weaknesses. Around 5% of partici-
pants sign up online. The most cost-efﬁcient methods of
recruitment have been direct face-to-face recruitment by
trained recruiters in outpatient departments (OPD) and
general practice surgeries (positive response rates are
around 90%, with the more successful recruiters man-
aging to recruit around 20 per hour, costing ∼40p
($0.52) per recruit). Emails to employees from organisa-
tions (eg, university, government departments) are also
successful, returning around 10% positive replies and
costing very little but can only be applied once. Leaﬂets
posted out with outpatient letters produce a similar
return and are relatively low cost to SHARE (between
65p and 85p ($0.87–1.18 per recruit). However, the
impact of inclusion of SHARE information on letter size
and weight can carry an additional cost to the NHS and
in several areas have been permitted for a limited
period only. Advertising on the radio, in newspapers and
on buses has contributed to raising awareness. All
SHARE participants are encouraged to let friends and
family know through social media. Social media adver-
tisements generated a great number of clicks but rela-
tively few signups.
Recruitment was initially slow; however, once the most
effective methods of recruitment were established and
focused on, particularly face-to-face approaches, recruit-
ment started to rise rapidly. On 2 March 2016, we
recruited our 100 000th participant. Our aim is to
achieve 250 000 by the end of 2017 and 1 million over
the next 5–10 years.
Figure 4 shows the age and sex distribution of the
SHARE cohort. More women than men have been
recruited. This reﬂects the populations attending out-
patient and general practice appointments and those
who accompany them.
Figure 3 Interception of spare blood for genomic research using SHARE.
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Withdrawal from SHARE
Participants are not committed to any further action or
taking part in any studies and can withdraw from the
register at any time by multiple routes including email,
mail or telephone. Currently, 363 individuals (0.3%) of
all registrants have withdrawn from further contact and
the majority of these are individuals who have become
too frail/ill to be involved in ongoing/further studies.
Only 33 individuals have withdrawn their consent to the
use of spare blood in research. Many elderly/frail indivi-
duals who might not have felt well enough to participate
in research have been very keen that they can continue
to contribute to health research by the use of their
spare blood.
RECRUITMENT TO STUDIES
Table 2 shows a selection of examples of the range of
studies to which SHARE has recruited and the ratio of
the number of approaches to positive responses and to
actual recruitment. Several of these were ‘rescue’ proce-
dures for studies which had failed to successfully recruit
using traditional recruitment methods and were there-
fore particularly challenging. SHARE has now recruited
to 36 studies, and currently SHARE is considering 22
new studies.
ETHICS
SHARE has NHS research ethics approval to approach
patients attending NHS facilities to ask them to become
part of SHARE and to use their stored data to identify
them as potentially suitable participants in medical
research. SHARE may only be used by applicants who
have the appropriate NHS ethics approval to recruit par-
ticipants to their study. The use of SHARE to recruit
people to patient and public involvement panels does
not require ethical approval.
Table 1 Recruitment methods to SHARE
Recruitment method Strengths Weaknesses
Face-to-face recruitment in
OPD and GP
High sign-up rate (around 90% of those
approached agree to join), improves visibility of
research within the NHS
Labour intensive, recruiter dependent
Letters included with OPD
appointments
Return rate 10%. Where accompanied by
personal letter from consultant, it rises to 17%.
Relies on goodwill of appointments staff. Time
of NHS admin staff, until now, has been given
free but cost may be a consideration in the
longer term
Direct email from institution
lead
Low cost, quick sign-up, most of whom have
viable email addresses which facilitates future
contacts. Around 10% sign up.
Can only really be performed infrequently.
Most larger organisations prefer to advertise
SHARE in internal staff news magazines, but
this diminishes impact.
Advertising on Radio
Buses
Parking tickets
Newspapers
Wide audience reach. Advertisements may
raise awareness which improves uptake when
participants are approached face to face.
Expensive and not clear to what extent it
contributes to overall participation.
Facebook advertisements Targets a younger audience than that of OPD
clinics
Large numbers of website clicks but relatively
few sign-ups
GP, general practitioner; OPD, outpatient department; NHS, National Health Service.
Figure 4 Current age, sex
distribution of the SHARE cohort.
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For the spare blood samples, the appropriate accre-
dited NHS Tissue Bank provides governance of the
samples, overseeing secure sample storage, access and
release. All biological information measured in these
samples, including genomics, is returned to the central
database to be made available for further research and
potential clinical use. The full details of the information
provided to registrants are available at http://www.
registerforshare.org/any-questions.php#tayside.
FUNDING
SHARE is funded by NHS Research Scotland (NRS)
(http://www.nhsresearchscotland.org.uk/), a partner-
ship of Scottish Health Boards and the Scottish
Government Chief Scientist Ofﬁce (CSO) that oversees
governance and management of clinical research. Last
year, SHARE received just under £300 000 which is used
to pay for ongoing recruitment, database maintenance
and administration. Currently, a small cost is levied from
research teams on a cost recovery basis to pay for
postage and administrative time in contacting potential
participants; however, a more sustainable cost recovery
approach is foreseen. SHARE is based on a pilot study
funded by CSO.
GOVERNANCE AND OPERATIONS
Each of the four nodes of NRS (North, South, East and
West) contains informatics ‘safe havens’ that manage the
collection and linkage of health records in a secure
environment within a strong governance framework.
Local Privacy Advisory Committees operate to oversee
governance issues and to provide support to researchers
in the design and conduct of studies. All transfers of
potentially identiﬁable data (including the CHI
number) within the NHS are conducted in accordance
with local and national data security policies.
To reduce the risk of accidental disclosure, contacts
with potential participants are couched in neutral terms.
Contact information is carefully designed not to reveal
why a potential participant has been approached for a
Table 2 Examples of SHARE involvement in recruitment to different types of study challenge
Study Challenge Detail
Number
approached
Number
delivered to
researcher
Number
entered
into study
SPIROA
The Effect of
Spironolactone on
Pain in Older People
with Osteoarthritis
Required data
from both primary
and secondary
care
This study sought to recruit
people with osteoarthritis and
knee pain who had not been on
NSAIDs, ACE inhibitors or
spironolactone. They required
eight additional participants
before a 2-week deadline
25 16 8
DIRECT
DIabetes REmission
Clinical Trial
Rescue before
recruitment
closure
This study required recently
diagnosed people with diabetes
within 3 weeks before study
closure
12 8 2
DECIDE
Decision-making and
comprehension of
interactive and static
Summary of
Findings tables.
Large-scale
survey
Complex survey exploring
preferences for presentation of
risk which had struggled to get
responses. 20% response was
desired.
However, the survey was only
compatible with desktop
operating systems and therefore
was inaccessible to the large
numbers of registrants who
clicked through from mobile
devices.
50 000 16 266 viewed full
email, 9183
clicked and
attempted survey
Over 2000
completed.
H. PYLORI
Infection And Acid
Secretory Function
Anticipated high
refusal rate
Study which required 150
healthy volunteers willing to
undergo endoscopy
1400 251 150
REFORM— Finding people
with multiple
morbidity
Research into the Effect Of
SGLT2 inhibition on left
ventricular remodelling in
patients with heart failure and
diabetes mellitus
63 27 15
NSAIDs, non-steroidal anti-inflammatory drugs.
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particular study. If, as a result, the recruitment team is
asked why contact was made, the response is that the
potential participant may or may not have a condition of
interest. We do not pass on any information from the
medical records. Potential participants are given details
about the study and told that they may be eligible to par-
ticipate if the inclusion/exclusion criteria apply to them
and they are interested.
Day-to-day management of the Register (awareness-
raising, literature, recruitment, validation, access, the
website, the database) is currently though a project man-
agement subcommittee (two directors (CP and BMcK)
and project manager (SV)). Weekly meetings provide
for liaison with media advisers, website programmers
and an informatics lead with monthly telephone meet-
ings of a project management group compromising
representatives of all four NHS nodes. These members
also provide rapid assessment of applications to use
SHARE. A steering group meets twice yearly and
includes management group members along with repre-
sentatives of the Chief Scientist Ofﬁce and a patient
representative.
CHALLENGES
Current challenges include lack of access to primary
care data sets and the quality of some of the data sets.
The former is being addressed by the formation of
SPIRE, a centralised repository of general practice
data.15 Although the Scottish Morbidity Record (SMR)
data are well validated,16 the coding can be limited and
frequently lists only the main condition for admission
with little information on comorbidities and the
International Classiﬁcation of Diseases 10th Revision
coding may also lack the detail required.17 Health
Boards frequently hold more detailed electronic data
but quality can be problematic as can coding in
general practice for conditions other than those incen-
tivised by the Quality Outcomes Framework.18 However,
improved access to GP records will provide information
on physiological measurements such as blood pressure,
weight and peak expiratory ﬂow, which are routinely
recorded.
Recruitment to SHARE is currently labour intensive
and, as the register grows, maintenance will also be chal-
lenging. We are exploring ways to routinise the offer to
join SHARE on registering with a general practitioner
and attending hospital clinics. Although SHARE is cur-
rently supported by the Scottish Chief Scientist Ofﬁce
(CSO), future operations may increasingly need to be
supported by charges to researchers using SHARE,
aiming to be eventually self-ﬁnancing.
It is only in the past year that SHARE has achieved a
critical mass to be a viable source of recruitment for
researchers and studies until now have largely been
testing SHARE’s systems. We have recently started adver-
tising SHARE throughout Scotland and interest among
researchers has risen, with a large proportion of recent
funding applications to the CSO stating that intended
recruitment would be facilitated by SHARE.
RECENT AND FUTURE DEVELOPMENTS
We have recently added a clinical trials portal to inform
the public about research participation opportunities.
This provides details of research projects by condition
and by geographical area of the study and the type of
participant being sought. This will allow potential parti-
cipants to check some of their eligibility characteristics
for these trials with a simple questionnaire and, if they
meet these requirements, the option of contacting the
trialists for further information and assessment. A web
portal which will allow researchers to search SHARE at a
high level of anonymous data to determine likely
numbers of participants with particular broad inclusion
and exclusion criteria for their trial is planned. This will
have some appropriate limitations to ensure that
searches are not disclosive, that is, that individual partici-
pants cannot be identiﬁed. We are developing a smart-
phone app which will provide similar functions to that
above but, in addition, will be available to be used for
questionnaire studies, gathering epidemiological data,
participant-related outcome measures and, potentially,
activity and location data if the participant permits
these.
CONCLUSION
In conclusion, SHARE has demonstrated that large
numbers of members of the public are willing to allow
their personal data to be used to identify them for poten-
tial research projects and also for their ‘spare blood’ to
be used for research. Altruism, and also the hope that
research may beneﬁt either them or family members and
their trust in the NHS that their data will be kept conﬁ-
dential, underpins this.14 The register has been successful
in recruiting to some more challenging studies. The
register in Scotland has been established with a relatively
modest amount of resource (circa £300 000 ($400 000)
per annum in the set-up phase), but has demonstrated
the potential to greatly facilitate recruitment to and
reduce the costs of high-quality research.
For people who may wish to participate and research-
ers who may wish to use SHARE, details can be found at
http://www.registerforshare.org.
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